Related Experiment Video

Updated: Mar 20, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.4K

Lethargy and vision loss: successful management of rhinocerebral mucormycosis

Ramzi Mulki1, Muhammad Masab1, Glenn Eiger1

  • 1Einstein Medical Center, Philadelphia, Pennsylvania, USA.

BMJ Case Reports
|June 4, 2016
PubMed

Insights

Rhinocerebral mucormycosis (RCM), a fungal infection, can be successfully managed in diabetic patients. This case report details the diagnostic and therapeutic strategies for a severe RCM presentation.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neurology

Background:

  • Rhinocerebral mucormycosis (RCM) is a severe angioinvasive fungal infection, often caused by Rhizopus oryzae.
  • It typically affects immunocompromised individuals and carries a poor prognosis.
  • Optimal management strategies for RCM remain undefined, relying heavily on case reports and expert opinions.

Observation:

  • A case of RCM in an insulin-dependent diabetic patient presented with altered mental status.
  • The condition rapidly progressed to complete right eye blindness and ophthalmoplegia.
  • Complications included multiple cerebral infarctions and abscesses.

Findings:

  • The patient's RCM was successfully managed through a comprehensive diagnostic and therapeutic approach.
  • Early identification and intervention are crucial for improving outcomes in RCM.

Implications:

  • This case highlights the importance of considering RCM in diabetic patients with neurological and ophthalmological symptoms.
  • Successful management underscores the need for tailored treatment protocols for aggressive fungal infections.
  • Further research into standardized RCM treatment guidelines is warranted to improve patient survival rates.

More Related Videos

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice08:25

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

Published on: July 16, 2014

11.3K
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.6K

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.0K
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
699
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
605
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
745